This cancer therapy targets the disease with the help of the patient’s own immune system
Dr. Mike Jensen led a research team at Seattle Children’s Research Institute that conducted a clinical trial using T cell immunotherapy to treat a type of leukemia in children. Of those enrolled in the trial, 93 percent achieved complete remission
Join the Must List
Subscribe today to have Seattle's best events delivered to your inbox!